ArticleScientific reports2026
Exploring the antibacterial mechanism and application of lavender essential oil based on network pharmacology and molecular docking.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
In this study, essential oil was extracted from lavender using steam distillation, and its chemical components were identified by gas chromatography-mass spectrometry (GC-MS). The active ingredients of lavender essential oil (LEO) and their corresponding targets were obtained from the STP, SEA, and TCMSP databases. The antibacterial activities of the active components in LEO were investigated against Escherichia coli, Staphylococcus aureus, Bacillus subtilis, and Candida albicans. The antibacterial efficacy was evaluated by measuring the diameter of the inhibition zone and the minimum inhibitory concentration (MIC). The results showed that 156 common targets were identified by intersecting the component targets of LEO and the host targets related to antibacterial activity. Topological analysis was performed using Cytoscape software, and 21 potential core targets were finally obtained through two rounds of screening based on topological indexes. Gene Ontology (GO) enrichment analysis revealed that these targets were mainly involved in biological processes such as transcriptional regulation, while Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis indicated their participation in 169 signaling pathways. Molecular docking results demonstrated that the core targets exhibited strong binding affinity with the four key components. In vitro antibacterial experiments verified that linalool, linalyl acetate, 1,8-cineole, and caryophyllene all showed favorable antibacterial activity. Combining network pharmacology, molecular docking, and in vitro antibacterial assays, this study clearly distinguished the direct antibacterial effect of lavender essential oil from its indirect anti-infectious role via host immune regulation. This work clarified the material basis for direct bacteriostasis and the auxiliary mechanism at the host level, providing an important reference for the potential application of lavender essential oil in the field of antibacterial treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.